GlassScriptPhysician profile
Sonia Watley
NPI 1770878498
$4,476.63
in general payments reported to CMS, 2019-2025
37 companies · $926 in 2025
The $926 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $180 · 2021: $461 · 2022: $669 · 2023: $918 · 2024: $1,323 · 2025: $926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,167.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $973.67 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $599.76 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $493.21 | 2020-2025 | |
| Abbvie INC. | $453.98 | 2021-2025 | Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $327.87 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $241.73 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $116.11 | 2024-2025 | Veozah |
| Phathom Pharmaceuticals, INC. | $110.71 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $107.54 | 2020-2025 | Airsupra |
| Amgen INC. | $97.16 | 2022-2024 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $94.96 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $94.03 | 2023-2025 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.50 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $65.90 | 2023-2025 | Gemtesa |
| Cranial Technologies, INC | $57.92 | 2022-2025 | Doc Band |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Watley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.